Why the study?
Does N-acetylprocainamide have different electrophysiological effects compared to procainamide in the anaesthetized dog heart?
Does N-acetylprocainamide have different electrophysiological effects compared to procainamide in the anaesthetized dog heart?
N-acetylprocainamide, the major metabolite of procainamide, exhibits distinct electrophysiological properties in the dog heart, notably lacking the conduction-delaying effects on the His-Purkinje system and AV node seen with the parent drug.
Answers are grounded in this paper and cite their sources.
Supports distinct electrophysiological effects of N-acetylprocainamide in dogs; leaves open clinical translation for human arrhythmia therapy.
The electrophysiological effects of procainamide and its major metabolite N-acetylprocainamide were tested and compared on the heart of the anaesthetized dog by means of His bundle electrography and programmed electrical stimulation. Both drugs exerted a negative chromotropic effect. They also increased intra-atrial and intraventricular conduction times; procainamide was, however, the more potent of the two drugs. In contrast to procainamide, N-caetylprocainamide did not increase His-Purkinje and atrioventricular nodal conduction times, and at the lowest dose employed, atrioventricular nodal conduction times were decreased during atrial pacing. Both drugs increased the functional and effective refractory period of the right atrium and ventricle. N-acetylprocainamide increased the functional refractory period of the atrioventricular node, but to a lesser extent than procainamide.
No takes yet. Share an insight, caveat, or question.
Amlie et al. (1978) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: